Drug intelligence / Profile preview

Medicurtain PLUS

Development stage: Unknown
Lead developer: Shinpoong Pharma
Administration: Topical

Overview

Medicurtain PLUS is a medical device developed by Shin Poong Pharmaceutical for the prevention of post-surgical adhesions. It is a biocompatible, high-viscosity gel composed of sodium hyaluronate (HA). The device acts as a physical barrier between internal tissues and organs following surgery, preventing them from sticking together during the healing process. It is indicated for use in various surgical procedures, including abdominal, spinal, gynecological (hysteroscopic), thyroid, and nasal/sinus surgeries. Clinical evaluations have demonstrated its efficacy and safety in maintaining tissue separation and reducing the incidence of adhesion-related complications.

Brand names: Medicurtain PLUS
Other names: 메디커튼 PLUS

Beyond the preview

Go deeper on Medicurtain PLUS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicurtain PLUS.

Explore the full profile